<DOC>
	<DOCNO>NCT01801228</DOCNO>
	<brief_summary>This study compare Spironolactone , non-selective aldosterone antagonist , Eplerenone , selective aldosterone antagonist , regard efficacy hormonal side effect treat male cirrhotic patient uncomplicated ascites 6 month period . The investigator hypothesis Eplerenone effective Spironolactone treatment ascites less side effect painful gynecomastia .</brief_summary>
	<brief_title>Eplerenone Versus Spironolactone Treatment Ascites Due Liver Cirrhosis ; Study Efficacy Side Effects</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<criteria>Male Ascites Cirrhosis Prior treatment aldosterone antagonist Uncontrolled heart disease diabetes Current malignancy Current medication interact aldosterone antagonist</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>